Literature DB >> 19381321

Pustules and dystrophy of the nails.

Lindsay E Boltan1, Alan Menter.   

Abstract

Entities:  

Year:  2009        PMID： 19381321      PMCID： PMC2666869          DOI： 10.1080/08998280.2009.11928505

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


× No keyword cloud information.
  6 in total

1.  Two years of experience with etanercept in recalcitrant psoriasis.

Authors:  K Ahmad; S Rogers
Journal:  Br J Dermatol       Date:  2007-04-04       Impact factor: 9.302

2.  Three years' experience with infliximab in recalcitrant psoriasis.

Authors:  K Ahmad; S Rogers
Journal:  Clin Exp Dermatol       Date:  2006-09       Impact factor: 3.470

3.  A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis.

Authors:  Alan Menter; Steven R Feldman; Gerald D Weinstein; Kim Papp; Robert Evans; Cynthia Guzzo; Shu Li; Lisa T Dooley; Cynthia Arnold; Alice B Gottlieb
Journal:  J Am Acad Dermatol       Date:  2006-09-06       Impact factor: 11.527

4.  Acrodermatitis continua of Hallopeau on toes successfully treated with a two-compound product containing calcipotriol and betamethasone dipropionate.

Authors:  Dimitrios Sotiriadis; Aikaterini Patsatsi; Eleni Sotiriou; Eleni Sotiriou; Ioannis Papagaryfallou; Fotis Chrysomallis
Journal:  J Dermatolog Treat       Date:  2007       Impact factor: 3.359

5.  Successful treatment of acrodermatitis continua of Hallopeau by the tumour necrosis factor-alpha inhibitor infliximab (Remicade).

Authors:  R Mang; T Ruzicka; H Stege
Journal:  Br J Dermatol       Date:  2004-02       Impact factor: 9.302

6.  Efficacy of granulocyte and monocyte adsorption apheresis for pustular psoriasis.

Authors:  Mariko Seishima; Yoko Mizutani; Yoshinao Shibuya; Chikako Nagasawa; Takahiko Aoki
Journal:  Ther Apher Dial       Date:  2008-02       Impact factor: 1.762
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.